HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2298803Generated: October 30, 2026
HCID 18378637, compound → HCID 86758696, compound
https://huagongshe.com/reaction/2298803
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | HCID 18378637 | HCID 18378637 | — |
| Reactant | HCID 86758697 | HCID 86758697 | — |
| Reactant | HCID 178527226 | HCID 178527226 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 86758696 | HCID 86758696 | 54.3% |
Reaction Steps
A mixture of 2-methoxy-4-(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)-carbonylbenzoic acid (200 mg), 4-amino-1-tert-butoxycarbonyl-2-methyl-1H-benzimidazole (152 mg), WSCD·HCl [water soluble carbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, 141 mg] and 1-hydroxybenzotiazole (100 mg) in N,N-dimethylformamide (5 ml) was stirred at room temperature overnight, and the mixture was diluted with ethyl acetate. The solution was washed successively with saturated aqueous sodium hydrogencarbonate solution, water, and brine and dried over magnesium sulfate. The solvent was evaporated and the residue was purified by silica gel column chromatography using chloroform as an eluent to give 2-methoxy-N-[2-methyl-1-(tert-butoxycarbonyl)-1H-benzimidazol-4-yl]-4-(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)-carbonylbenzamide (185 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06495542B1 |
|---|
| Source dataset | uspto-grants-2002_12 |
|---|
| ORD ID | ord-9a7a0bb4eff347b29defd26a4f3e34bd |
|---|
| Source note | uspto-grants-2002_12 |
|---|